Shopping Cart 0
Cart Subtotal
AED 0

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company's pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. It provides medical diagnostic products such as real time PCR detector, human papillomavirus assay kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company's research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai City, Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deal Details 13

Venture Financing 13

Paragon Genomics Raises USD8 Million in Series A Financing 13

Spirometrix Raises USD17.4 Million in Series C Financing 14

Check-Cap Raises Funds through Venture Financing 15

Saladax Biomedical Raises USD 23 Million In Series D Venture Financing 16

Private Equity 18

Butterfly Network Raises USD250 Million in Series D Financing 18

Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 19

PBM Capital Acquires Breas Medical From GE Healthcare 21

KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 22

Partnerships 23

Shanghai Fosun Pharma Plans to Form Joint Venture with Fosun International 23

Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 24

Astute Medical Enters into Distribution Agreement with Fosun Long March 25

CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 26

Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 27

Equity Offering 28

Shanghai Fosun Pharma Raises USD331 Million in Private Placement of Shares 28

Gland Pharma May Raise USD500 Million in IPO 30

Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 31

Chindex to Raise USD38.2 Million in Private Placement of Shares 33

Debt Offering 34

Shanghai Fosun Pharma Raises USD190.7 Million in Public Offering of 5.1% Bonds Due 2023 34

Shanghai Fosun Pharma to Raise USD791 Million in Public Offering of Bonds 35

Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 36

Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 37

Acquisition 38

Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 38

Fosun Pharma Acquires 80% stake in Breas Medical 39

Breas Medical Acquires B&D Electromedical 40

Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 41

Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 42

Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For USD 250 Million 43

Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 45

Shanghai Fosun Pharmaceutical (Group) Co Ltd-Key Competitors 46

Shanghai Fosun Pharmaceutical (Group) Co Ltd-Key Employees 47

Shanghai Fosun Pharmaceutical (Group) Co Ltd-Locations And Subsidiaries 49

Head Office 49

Other Locations & Subsidiaries 49

Recent Developments 50

Strategy And Business Planning 50

Sep 05, 2017: Sisram, the world's leading medical and medical device company under Fosun Pharma, plans to become the first listed Israeli company in Hong Kong 50

Jul 11, 2017: Rooted in Shanghai innovation Fosun Pharma Zhangjiang new R & D headquarters base was officially launched 52

Financial Announcements 54

Mar 27, 2018: Fosun pharma: Announcement of Final Results for the Year Ended 31 December 2017 54

Oct 31, 2017: Fosun Pharma releases third quarter 2017 revenue up 21.83% YoY Research and development investment continues to increase 56

Aug 30, 2017: Fosun Pharma: R & D and international lighting performance, the first half revenue grew 20.41% 57

Jun 14, 2017: Fosun Pharma released first quarter 2017 revenue up 20.29% R & D investment continued to increase 59

Mar 31, 2017: Fosun Pharma non-net profit in 2016 increased by 26.36% year-on-year Continued to increase innovation and R & D investment Strengthen the layout of medical services 60

Corporate Communications 63

Mar 26, 2018: Change In Fosun Pharma's Board Of Directors To Further Align Group Strategy 63

Mar 26, 2018: Shanghai Fosun Pharmaceutical Announces Personnel Changes 64

Legal and Regulatory 66

Sep 05, 2017: Fosun Pharmas Subsidiary Sisram, the World's Leading Energy-Based Medical Aesthetic Treatment Systems Provider, to be Listed as the First Israeli Company on the Main Board of SEHK 66

Appendix 68

Methodology 68

About GlobalData 68

Contact Us 68

Disclaimer 68


List Of Figure

List of Figures

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Key Facts, 2017 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Deals By Market, 2012 to YTD 2018 9

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Paragon Genomics Raises USD8 Million in Series A Financing 13

Spirometrix Raises USD17.4 Million in Series C Financing 14

Check-Cap Raises Funds through Venture Financing 15

Saladax Biomedical Raises USD 23 Million In Series D Venture Financing 16

Butterfly Network Raises USD250 Million in Series D Financing 18

Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 19

PBM Capital Acquires Breas Medical From GE Healthcare 21

KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 22

Shanghai Fosun Pharma Plans to Form Joint Venture with Fosun International 23

Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 24

Astute Medical Enters into Distribution Agreement with Fosun Long March 25

CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 26

Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 27

Shanghai Fosun Pharma Raises USD331 Million in Private Placement of Shares 28

Gland Pharma May Raise USD500 Million in IPO 30

Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 31

Chindex to Raise USD38.2 Million in Private Placement of Shares 33

Shanghai Fosun Pharma Raises USD190.7 Million in Public Offering of 5.1% Bonds Due 2023 34

Shanghai Fosun Pharma to Raise USD791 Million in Public Offering of Bonds 35

Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 36

Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 37

Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 38

Fosun Pharma Acquires 80% stake in Breas Medical 39

Breas Medical Acquires B&D Electromedical 40

Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 41

Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 42

Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For USD 250 Million 43

Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 45

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors 46

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees 47

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries 49

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company's pharmaceutical products include metabolism and digestive system, cardiovascular system, blood system, central nervous system drugs, anti-infection, anti-tumor, vaccine and raw material and intermediates. It provides medical diagnostic products such as real time PCR detector, human papillomavirus assay kit, HBV quantitative reagent, and biofosun microorganism identification and susceptibility analysis system. The company's research and development unit concentrates on therapeutic areas of metabolism and digestive system, blood system, cardiovascular system and central nervous system. Fosun Pharma is headquartered in Shanghai City, Shanghai, China.

Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deal Details 13

Venture Financing 13

Paragon Genomics Raises USD8 Million in Series A Financing 13

Spirometrix Raises USD17.4 Million in Series C Financing 14

Check-Cap Raises Funds through Venture Financing 15

Saladax Biomedical Raises USD 23 Million In Series D Venture Financing 16

Private Equity 18

Butterfly Network Raises USD250 Million in Series D Financing 18

Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 19

PBM Capital Acquires Breas Medical From GE Healthcare 21

KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 22

Partnerships 23

Shanghai Fosun Pharma Plans to Form Joint Venture with Fosun International 23

Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 24

Astute Medical Enters into Distribution Agreement with Fosun Long March 25

CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 26

Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 27

Equity Offering 28

Shanghai Fosun Pharma Raises USD331 Million in Private Placement of Shares 28

Gland Pharma May Raise USD500 Million in IPO 30

Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 31

Chindex to Raise USD38.2 Million in Private Placement of Shares 33

Debt Offering 34

Shanghai Fosun Pharma Raises USD190.7 Million in Public Offering of 5.1% Bonds Due 2023 34

Shanghai Fosun Pharma to Raise USD791 Million in Public Offering of Bonds 35

Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 36

Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 37

Acquisition 38

Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 38

Fosun Pharma Acquires 80% stake in Breas Medical 39

Breas Medical Acquires B&D Electromedical 40

Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 41

Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 42

Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For USD 250 Million 43

Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 45

Shanghai Fosun Pharmaceutical (Group) Co Ltd-Key Competitors 46

Shanghai Fosun Pharmaceutical (Group) Co Ltd-Key Employees 47

Shanghai Fosun Pharmaceutical (Group) Co Ltd-Locations And Subsidiaries 49

Head Office 49

Other Locations & Subsidiaries 49

Recent Developments 50

Strategy And Business Planning 50

Sep 05, 2017: Sisram, the world's leading medical and medical device company under Fosun Pharma, plans to become the first listed Israeli company in Hong Kong 50

Jul 11, 2017: Rooted in Shanghai innovation Fosun Pharma Zhangjiang new R & D headquarters base was officially launched 52

Financial Announcements 54

Mar 27, 2018: Fosun pharma: Announcement of Final Results for the Year Ended 31 December 2017 54

Oct 31, 2017: Fosun Pharma releases third quarter 2017 revenue up 21.83% YoY Research and development investment continues to increase 56

Aug 30, 2017: Fosun Pharma: R & D and international lighting performance, the first half revenue grew 20.41% 57

Jun 14, 2017: Fosun Pharma released first quarter 2017 revenue up 20.29% R & D investment continued to increase 59

Mar 31, 2017: Fosun Pharma non-net profit in 2016 increased by 26.36% year-on-year Continued to increase innovation and R & D investment Strengthen the layout of medical services 60

Corporate Communications 63

Mar 26, 2018: Change In Fosun Pharma's Board Of Directors To Further Align Group Strategy 63

Mar 26, 2018: Shanghai Fosun Pharmaceutical Announces Personnel Changes 64

Legal and Regulatory 66

Sep 05, 2017: Fosun Pharmas Subsidiary Sisram, the World's Leading Energy-Based Medical Aesthetic Treatment Systems Provider, to be Listed as the First Israeli Company on the Main Board of SEHK 66

Appendix 68

Methodology 68

About GlobalData 68

Contact Us 68

Disclaimer 68


List Of Figure

List of Figures

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Key Facts, 2017 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Deals By Market, 2012 to YTD 2018 9

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Paragon Genomics Raises USD8 Million in Series A Financing 13

Spirometrix Raises USD17.4 Million in Series C Financing 14

Check-Cap Raises Funds through Venture Financing 15

Saladax Biomedical Raises USD 23 Million In Series D Venture Financing 16

Butterfly Network Raises USD250 Million in Series D Financing 18

Healthy Harmony and Shanghai Fosun Pharma Acquire Chindex International in Going Private Transaction for USD461 Million 19

PBM Capital Acquires Breas Medical From GE Healthcare 21

KKR Receives Government Approval To Acquire 35% Stake In Gland Pharma For USD200 Million 22

Shanghai Fosun Pharma Plans to Form Joint Venture with Fosun International 23

Intuitive Surgical to Form Joint Venture with Shanghai Fosun Pharma 24

Astute Medical Enters into Distribution Agreement with Fosun Long March 25

CareFusion Enters into Distribution Agreement with Breas Medical for Vivo Line of Ventilators 26

Miacom Diagnostics Enters into Co-Marketing Agreement with Fosun Diagnostics 27

Shanghai Fosun Pharma Raises USD331 Million in Private Placement of Shares 28

Gland Pharma May Raise USD500 Million in IPO 30

Shanghai Fosun Pharma to Raise USD298.3 Million in Private Placement of Shares 31

Chindex to Raise USD38.2 Million in Private Placement of Shares 33

Shanghai Fosun Pharma Raises USD190.7 Million in Public Offering of 5.1% Bonds Due 2023 34

Shanghai Fosun Pharma to Raise USD791 Million in Public Offering of Bonds 35

Shanghai Fosun Pharma Plans to Raise up to USD1 Billion in Private Placement of Bonds 36

Shanghai Fosun Pharma Raises USD65.3 Million in First Tranche of Private Placement of 3.95% Notes Due 2018 37

Shanghai Fosun Pharma to Acquire 65% Stake in SinoMedCare Biotech for USD40 Million 38

Fosun Pharma Acquires 80% stake in Breas Medical 39

Breas Medical Acquires B&D Electromedical 40

Shanghai Fosun Pharma Acquires 37% Stake in miacom diagnostics 41

Shanghai Fosun to Acquire 35% Stake in Sinopharm Holding Medical Investment Management from Sinopharm Group for up to USD32.4 Million 42

Fosun Pharma And Pramerica-Fosun China Opportunity Fund Complete Acquisition Of 95.6% Stake In Alma Lasers For USD 250 Million 43

Shanghai Fosun Pharma Acquires 17.65% Stake In SD Biosensor, In Vitro Diagnostics Company 45

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Competitors 46

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Key Employees 47

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Subsidiaries 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Shanghai Fosun Pharmaceutical (Group) Co Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.